Ai: Irl

The pharmaceutical industry is a lot like Texas. Everything is bigger there. Development costs are in the billions of dollars. Drug trials can last as long as a decade because they can’t find enough patients. On the most recent AI:IRL podcast, I spoke with Amitabh P. Mishra, President and Global CTO at Emcure Pharma Group, about how AI is changing his business and other industries as well. Mishra believes that artificial intelligence has the potential to facilitate every stage of the clinical trials process from matching eligible patients with studies to the data collection processes.